Advertisement

Topics

Residual Risk Reduction Initiative Foundation Company Profile

05:30 EDT 20th September 2017 | BioPortfolio


News Articles [3830 Associated News Articles listed on BioPortfolio]

US aid to combat malaria in Africa is associated with reduced risk of childhood mortality

In a study published in PLOS Medicine, Aleksandra Jakubowski of the University of North Carolina at Chapel Hill, US, and colleagues show that funding from the US President's Malaria Initiative (PMI) i...

New $225M initiative aims to reduce global burden of CVD

Body:  Thomas R. Frieden, MD, former director of the Centers for Disease Control and Prevention (CDC), is launching a global health initiative to address cardiovascular disease and epidemic prepa...

Sildenafil should be avoided in valve disease with residual pulmonary hypertension, study suggests

Sildenafil should not be used to treat residual hypertension in patients with valvular heart disease, according to new research. The off-label use of the drug led to worse clinical outcomes including ...

Former CDC Chief Frieden’s New Initiative Will Focus On Heart Health, Epidemic Preparedness

The $225 million in funding for the initiative -- called Resolve -- comes from some of the biggest names in global public health: Bloomberg Philanthropies ($100 million), the Chan Zuckerberg Initiativ...

Dr. Tom Frieden To Lead New Global Health Initiative, Backed By $225 Million In Funding From Bloomberg Philanthropies, The Chan Zuckerberg Initiative, And The Bill & Melinda Gates Foundation

  Life Sciences Jobs   ...

Dementia education on risk inspires people in midlife to consider healthier lifestyles

75 percent of people said advice on dementia risk reduction would encourage them to adopt a healthier lifestyle. Three quarters of people in midlife would make lifestyle changes now to reduce their ri...

Sildenafil should be avoided in valve disease with residual pulmonary hypertension

(European Society of Cardiology) Sildenafil should not be used to treat residual hypertension in patients with valvular heart disease, according to late-breaking results from the SIOVAC trial presente...

Inflammation reduction could cut risk of heart attack, stroke

A significant reduction in risk of recurrent heart attacks, strokes, and cardiovascular death was found among people who received a targeted anti-inflammatory drug that lowered inflammation but had no...

Drugs and Medications [565 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [7050 Associated PubMed Articles listed on BioPortfolio]

Reduction of LDL-C-related residual cardiovascular risk with ezetimibe: are mechanistic considerations warranted in practice?

South Asian Health. From Research to Practice and Policy: An Overview.

The US South Asian population has grown tremendously, and is now over 2.5 million. South Asians often face tremendous cultural, socioeconomic, linguistic and structural obstacles to good health, and f...

Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general population.

Alcohol dependence is often untreated. Although abstinence is often the aim of treatment, many drinkers prefer drinking reduction goals. Therefore, if supported by evidence of benefit, drinking reduct...

5-HT6 Receptor Antagonist as an Adjunct Treatment Targeting Residual Symptoms in Patients With Schizophrenia: Unexpected Sex-Related Effects (Double-Blind Placebo-Controlled Trial).

Treating patients who experience residual psychotic symptoms during remission of schizophrenia remains one of the most challenging problems. The mechanisms underlying these symptoms differ from those ...

Adjunctive therapy with statins reduces residual albuminuria/proteinuria and provides further renoprotection by downregulating the angiotensin II-AT1 pathway in hypertensive nephropathy.

Blockade of the renin-angiotensin II (Ang II) system by AT1 blockers (ARBs) and angiotensin-converting enzyme inhibitors retards the progression of chronic kidney disease (CKD) by reducing albuminuria...

Clinical Trials [5622 Associated Clinical Trials listed on BioPortfolio]

The Effect of Age on the Incidence of Postoperative Residual Neuromuscular Blockade

Residual neuromuscular blockade is frequently observed in the early postoperative period when patients have received a general anesthetic with muscle relaxants. At the present time it is ...

Ohio Colorectal Cancer Prevention Initiative

The purpose of the Ohio Colorectal Cancer Prevention Initiative (OCCPI) is to reduce morbidity and mortality due to colorectal cancer (CRC) in the state of Ohio. By identifying individuals...

Effectiveness of an Abstinence-Only HIV/Sexually Transmitted Disease Risk-Reduction Intervention for Young African-American Adolescents

This study will develop and evaluate the effectiveness of culturally appropriate HIV/sexually transmitted disease risk-reduction interventions in reducing sexual risk behavior among young ...

Discharge ALERT: Quality Improvement Initiative

Brigham and Women's Hospital will coordinate a Quality Improvement Initiative at other hospitals that focuses on whether physician notification prior to discharge of high risk VTE patients...

Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of Metastases

Circulating tumour DNA (ctDNA) is a promising tool when monitoring the residual disease in colorectal cancer (CRC). Current staging procedures are insufficient to identify the patient coho...

Companies [2445 Associated Companies listed on BioPortfolio]

Residual Risk Reduction Initiative Foundation

Residual Risk Reduction initiative (R3i)

PeriGen, Inc.

PeriGen is a technology-enabled professional services company specializing in risk reduction and clinical quality improvement in Obstetrics and is the only OB-specific risk reduct...

AGree

AGree is designed to tackle long-term food and agriculture issues. AGree is a collaborative initiative of nine of the world’s leading foundations, including the Ford Foundati...

Dance 4 Your Life!

Founded by the Dizzy Feet Foundation and the Larry King Cardiac Foundation, with the assistance of CRT/tanaka, in 2011, Dance 4 Your Life! is a national initiative to promo...

More Information about "Residual Risk Reduction Initiative Foundation" on BioPortfolio

We have published hundreds of Residual Risk Reduction Initiative Foundation news stories on BioPortfolio along with dozens of Residual Risk Reduction Initiative Foundation Clinical Trials and PubMed Articles about Residual Risk Reduction Initiative Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Residual Risk Reduction Initiative Foundation Companies in our database. You can also find out about relevant Residual Risk Reduction Initiative Foundation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record